US Patent Issued to Cambridge Enterprise on Jan. 27 for "Compounds for use as apelin receptor antagonists" (British Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,498, issued on Jan. 27, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain).

"Compounds for use as apelin receptor antagonists" was invented by Anthony Peter Davenport (Bourn, Great Britain), Robert Charles Glen (Suffolk, Great Britain) and Janet Julie Maguire (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to synthetic polypeptide compounds which bind to a class A G-protein-coupled receptor, the Apelin receptor. These compounds may act as apelin receptor antagonists. These compounds and compositions comprising them may be useful in the treatment of diseases, such as cancer."

T...